Milestone achieved in Scribe and Lilly’s ongoing collaboration to develop in vivo CRISPR-based therapeutics for neurological and neuromuscular diseasesAchievement validates Scribe’s technologies and ...

Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively cured through the use of CRISPR gene editing technology. But the rollout of ...

A new CRISPR-based one-off procedure that lowers "bad" cholesterol is expected to enter Phase I human trial in 2026. If successful, it could be the first approved genetic-silencing method on the ...

Seth Rogen took home the award for Best Actor in a TV Series Musical or Comedy at the 2026 Golden Globes on Sunday for his role in The Studio. It marked his first win at the awards show, but it was ...

Crispr Therapeutics remains highly volatile, disconnected from near-term fundamentals, yet I see long-term value far above current levels. CRSP's business progress is slow, with pipeline milestones ...

Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is repeatable. The funding has enabled CRISPR co-inventor Jennifer Doudna, Ph.D., and baby KJ scientist ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...

Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...

Attorney General Pam Bondi announced the Justice Department will send additional federal prosecutors to Minnesota amid an expanding fraud investigation tied to Somali-run nonprofit operations. "The ...

A new study led by scientists from the Hebrew University of Jerusalem and INSERM identified genes essential for turning embryonic stem cells into brain cells, including a gene linked to a previously ...